Oxygen outweighs every other element in the human body, a fact confirmed across peer-reviewed biomedical literature and one that quietly shapes how hospitals calculate radiation doses for millions of patients each year. The foundational dataset behind those calculations, authored by Woodard and White and covering 56 distinct body tissues, dates to the 1980s and has never been replaced with new primary measurements. That gap raises a practical question: are modern patients, whose body-water fractions may differ from decades-old cadaver averages, receiving radiation doses calibrated to bodies that no longer match their own?
Why outdated tissue tables could affect radiation dosing
Radiation treatment planning depends on knowing exactly how much energy different tissues absorb, and that absorption depends on elemental composition. Because oxygen binds with hydrogen to form water, and water accounts for the bulk of soft-tissue mass, even small shifts in a patient’s actual water content can change how a beam deposits energy. Clinicians rely on reference tables to set those parameters. The most widely cited reference remains the Woodard and White paper published in a dosimetry journal, which reassessed and expanded tissue-composition data originally compiled by the International Commission on Radiological Protection in 1975.
That reassessment provided updated water, lipid, protein, and ash fractions along with elemental breakdowns for 56 body tissues. Dosimetry software, imaging calibration protocols, and Monte Carlo simulations still draw on these figures. The concern is straightforward: if the average patient’s body-water fraction has shifted since those measurements were taken, the assumed oxygen content feeding dose calculations may be systematically off. Hospitals could, in theory, detect such a drift by comparing archived treatment records against modern bioimpedance measurements of body water in the same patient populations. No published study has yet performed that comparison.
Primary evidence for oxygen’s dominance across 56 tissues
The claim that oxygen leads all elements by mass in the human body is not contested. A 2018 review article indexed by the U.S. National Library of Medicine states directly that oxygen is the most abundant chemical element by mass in the human body. The reason is chemical: roughly two-thirds of body mass is water, and oxygen constitutes about 89 percent of water’s molecular weight. Beyond water, oxygen appears in proteins, nucleic acids, carbohydrates, and mineral salts, reinforcing its mass dominance in virtually every tissue type.
Woodard and White’s contribution was to quantify that dominance tissue by tissue. Their paper, cataloged by the U.S. Department of Energy, broke each of 56 tissues into elemental fractions, giving medical physicists the granular data needed to model how photons, electrons, and heavier particles interact with specific organs. Before that work, dosimetry models relied on broader ICRP 1975 averages that grouped tissues into fewer categories. The Woodard and White tables added precision that treatment-planning systems adopted and still use.
Because oxygen’s share varies from tissue to tissue, the clinical stakes are real. Adipose tissue contains less water and therefore less oxygen per gram than muscle or liver. A treatment plan that assumes a generic soft-tissue oxygen fraction for a region that is actually fat-heavy will miscalculate dose deposition. The Woodard and White tables addressed this by providing distinct compositions for tissues ranging from blood to bone marrow to cartilage, but the underlying measurements came from cadaver samples collected decades ago.
Gaps in the elemental record that clinicians still face
Three specific limitations stand between the existing data and confident modern dosimetry. First, the primary tissue-composition datasets stop at 1980s-era averages and lack stratified breakdowns by age, sex, or disease state. A 70-year-old woman undergoing breast radiation and a 30-year-old man receiving proton therapy for a brain tumor share the same reference oxygen fractions in planning software, even though their body compositions differ substantially.
Second, no direct in-vivo elemental assays from living subjects exist in the published record. All figures trace back to cadaver or biopsy aggregates. Living tissue hydration fluctuates with medication, disease progression, and even time of day, none of which cadaver data can capture. Bioimpedance devices now measure total body water in seconds at the bedside, yet no research team has systematically fed those readings back into tissue-composition tables to test whether the Woodard and White values still hold for current patient populations.
Third, recent dosimetry papers continue to cite the Woodard and White tables but supply no new primary measurements to verify their stability over time. The field treats the 1980s data as settled science while the population it describes has changed in average body mass index, hydration habits, and chronic disease prevalence. Each of those factors can shift body-water fraction and, by extension, the oxygen content that dose models assume.
A practical agenda for updating oxygen assumptions
For patients and clinicians, the practical next step is narrow but clear. Any hospital with both archived treatment plans and access to modern bioimpedance equipment could run a retrospective audit, comparing the body-water values assumed in past dose calculations against measured values in current patients drawn from the same catchment area. Even a modest sample-dozens of adults across age brackets-could reveal whether the reference soft-tissue compositions still approximate reality or whether systematic offsets have crept in.
Such an audit would not require exotic technology. Most radiation oncology departments already retain anonymized dose plans, including the tissue-density maps that planning systems derived from CT scans. By pairing those maps with fresh measurements of total body water and, where possible, regional fat and lean mass estimates from dual-energy X-ray absorptiometry, physicists could infer whether the oxygen fractions embedded in their software remain appropriate. If discrepancies emerged, they could be quantified and translated into correction factors for specific patient subgroups.
Parallel efforts could revisit the original tissue categories themselves. The 56-tissue framework reflects what could be sampled and analyzed in the 1970s and 1980s, not necessarily the most clinically relevant groupings today. Contemporary oncology distinguishes between subtypes of adipose tissue, fibroglandular breast tissue, and tumor microenvironments with markedly different vascularity and hydration. While the Woodard and White tables remain the backbone of current models, they were never designed to capture that level of biological nuance.
Updating elemental compositions would also dovetail with advances in treatment modalities. Proton and heavy-ion therapies, for example, are acutely sensitive to the stopping power of tissues along the beam path, which in turn depends on electron density and elemental mix. As more centers adopt these modalities, the cost of even small systematic errors in assumed oxygen content grows. A refreshed dataset could therefore improve not only the accuracy of conventional photon therapy but also the precision of emerging particle treatments.
Balancing stability with the need for revision
There are reasons the field has leaned on a single set of tissue tables for so long. Standardized compositions make it possible to compare dose-response data across trials, institutions, and decades. Constantly revising elemental fractions would complicate that continuity and might introduce new uncertainties if methods were not carefully harmonized. Any move to update oxygen assumptions must therefore balance the benefits of better fit to modern patients against the risk of fragmenting the dosimetric baseline.
A measured path forward would start with validation rather than wholesale replacement. Independent groups could reproduce the Woodard and White measurements using contemporary analytical chemistry on new cadaver series, explicitly matching tissue definitions and protocols wherever possible. Agreement within narrow bounds would strengthen confidence in the original tables; meaningful divergence would justify targeted updates. Either outcome would replace inference with evidence.
For now, clinicians planning radiation treatments can take some reassurance from the fact that oxygen’s dominance is not in doubt, and that the existing tables were built with considerable care. The unresolved question is whether the precise fractions that underpin those tables still mirror the bodies lying on treatment couches today. Until hospitals or research consortia test that assumption directly, dose calculations will continue to rest on an elegant, influential, but aging model of what human tissue is made of-and how much oxygen it really contains.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
